Revenue up 15% at research firm

Clinical research company Icon has reported a near 15% increase in first-half revenue to $529m (€437m).

However, despite a recovery in the second quarter of the year, net revenue for the six months to the end of June was down on a year-on-year basis by over 18%, from $25.9m to $21.9m.

The Dublin-based company — which acts as a global provider of outsourced development services to the pharmaceutical, biotechnology, and medical devices sectors — generated net revenue of $277m in the second quarter of the year, an increase of 19% on the same period last year.